✉  info@marketresearchfuture.com   📞  +1 (855) 661-4441(US)   📞  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

NGS-based RNA-sequencing Market Research Report Information By Product and Service (Sample Preparation Products, Sequencing Platforms and Consumables, Sequencing Services and Data Analysis, Storage and Management), By Technology (Sequencing by Synthesis (SBS), Ion Semiconductor Sequencing, Single-molecule Real-time Sequencing (SMRT), Nanopore Sequencing), By Application (Expression Profiling Analysis, Small RNA Sequencing, De Novo Transcriptome Assembly, Variant Calling and Transcriptome Epigenetics), By End-User (Research and Academia, Hos


ID: MRFR/HC/20519-HCR | 128 Pages | Author: Rahul Gotadki| November 2024

NGS-based RNA-sequencing Market Segmentation


NGS-based RNA-sequencing Product & Services Outlook (USD Billion, 2019-2032)




  • Sample Preparation Products




  • Sequencing Platforms and Consumables




  • Sequencing Services




  • Data Analysis, Storage and Management




NGS-based RNA-sequencing Technology Outlook (USD Billion, 2019-2032)




  • Sequencing By Synthesis (SBS)




  • Ion Semiconductor Sequencing




  • Single-molecule Real-time Sequencing (SMRT)




  • Nanopore Sequencing




NGS-based RNA-sequencing Application Outlook (USD Billion, 2019-2032)




  • Expression Profiling Analysis




  • Small RNA Sequencing




  • De Novo Transcriptome Assembly




  • Variant Calling and Transcriptome Epigenetics




NGS-based RNA-sequencing End-user Outlook (USD Billion, 2019-2032)




  • Research and Academia




  • Hospitals and Clinics




  • Pharmaceutical and Biotechnology Companies




NGS-based RNA-sequencing Regional Outlook (USD Billion, 2019-2032)




  • North America Outlook (USD Billion, 2019-2032)




  • North America NGS-based RNA-sequencing By Product & Services




    • Sample Preparation Products




    • Sequencing Platforms and Consumables




    • Sequencing Services




    • Data Analysis, Storage and Management








  • North America NGS-based RNA-sequencing By Technology







    • Sequencing By Synthesis (SBS)




    • Ion Semiconductor Sequencing




    • Single-molecule Real-time Sequencing (SMRT)







  • Nanopore Sequencing






  • North America NGS-based RNA-sequencing By Application




    • Expression Profiling Analysis








  • Small RNA Sequencing




  • De Novo Transcriptome Assembly




  • Variant Calling and Transcriptome Epigenetics






  • North America NGS-based RNA-sequencing By End-user






  • Research and Academia




  • Hospitals and Clinics






  • Pharmaceutical and Biotechnology Companies






  • US Outlook (USD Billion, 2019-2032)






  • US NGS-based RNA-sequencing By Product & Services




    • Sample Preparation Products




    • Sequencing Platforms and Consumables




    • Sequencing Services




    • Data Analysis, Storage and Management






  • US NGS-based RNA-sequencing By Technology







    • Sequencing By Synthesis (SBS)




    • Ion Semiconductor Sequencing




    • Single-molecule Real-time Sequencing (SMRT)







  • Nanopore Sequencing






  • US NGS-based RNA-sequencing By Application







    • Expression Profiling Analysis







  • Small RNA Sequencing




  • De Novo Transcriptome Assembly






  • Variant Calling and Transcriptome Epigenetics






  • US NGS-based RNA-sequencing By End-user






  • Research and Academia




  • Hospitals and Clinics






  • Pharmaceutical and Biotechnology Companies






  • CANADA Outlook (USD Billion, 2019-2032)




  • CANADA NGS-based RNA-sequencing By Product & Services




    • Sample Preparation Products




    • Sequencing Platforms and Consumables




    • Sequencing Services




    • Data Analysis, Storage and Management








  • CANADA NGS-based RNA-sequencing By Technology







    • Sequencing By Synthesis (SBS)




    • Ion Semiconductor Sequencing




    • Single-molecule Real-time Sequencing (SMRT)







  • Nanopore Sequencing






  • CANADA NGS-based RNA-sequencing By Application







    • Expression Profiling Analysis







  • Small RNA Sequencing




  • De Novo Transcriptome Assembly






  • Variant Calling and Transcriptome Epigenetics






  • CANADA NGS-based RNA-sequencing By End-user






  • Research and Academia




  • Hospitals and Clinics






  • Pharmaceutical and Biotechnology Companies






  • Europe Outlook (USD Billion, 2019-2032)




  • Europe NGS-based RNA-sequencing By Product & Services




    • Sample Preparation Products




    • Sequencing Platforms and Consumables




    • Sequencing Services




    • Data Analysis, Storage and Management








  • Europe NGS-based RNA-sequencing By Technology







    • Sequencing By Synthesis (SBS)




    • Ion Semiconductor Sequencing




    • Single-molecule Real-time Sequencing (SMRT)







  • Nanopore Sequencing






  • Europe NGS-based RNA-sequencing By Application







    • Expression Profiling Analysis







  • Small RNA Sequencing




  • De Novo Transcriptome Assembly






  • Variant Calling and Transcriptome Epigenetics






  • Europe NGS-based RNA-sequencing By End-user






  • Research and Academia




  • Hospitals and Clinics






  • Pharmaceutical and Biotechnology Companies






  • Germany Outlook (USD Billion, 2019-2032)




  • Germany NGS-based RNA-sequencing By Product & Services




    • Sample Preparation Products




    • Sequencing Platforms and Consumables




    • Sequencing Services




    • Data Analysis, Storage and Management








  • Germany NGS-based RNA-sequencing By Technology







    • Sequencing By Synthesis (SBS)




    • Ion Semiconductor Sequencing




    • Single-molecule Real-time Sequencing (SMRT)







  • Nanopore Sequencing






  • Germany NGS-based RNA-sequencing By Application







    • Expression Profiling Analysis







  • Small RNA Sequencing




  • De Novo Transcriptome Assembly






  • Variant Calling and Transcriptome Epigenetics






  • Germany NGS-based RNA-sequencing By End-user






  • Research and Academia




  • Hospitals and Clinics






  • Pharmaceutical and Biotechnology Companies






  • France Outlook (USD Billion, 2019-2032)




  • France NGS-based RNA-sequencing By Product & Services




    • Sample Preparation Products




    • Sequencing Platforms and Consumables




    • Sequencing Services




    • Data Analysis, Storage and Management








  • France NGS-based RNA-sequencing By Technology







    • Sequencing By Synthesis (SBS)




    • Ion Semiconductor Sequencing




    • Single-molecule Real-time Sequencing (SMRT)







  • Nanopore Sequencing






  • France NGS-based RNA-sequencing By Application







    • Expression Profiling Analysis







  • Small RNA Sequencing




  • De Novo Transcriptome Assembly






  • Variant Calling and Transcriptome Epigenetics






  • France NGS-based RNA-sequencing By End-user






  • Research and Academia




  • Hospitals and Clinics






  • Pharmaceutical and Biotechnology Companies






  • UK Outlook (USD Billion, 2019-2032)




  • UK NGS-based RNA-sequencing By Product & Services




    • Sample Preparation Products




    • Sequencing Platforms and Consumables




    • Sequencing Services




    • Data Analysis, Storage and Management








  • UK NGS-based RNA-sequencing By Technology







    • Sequencing By Synthesis (SBS)




    • Ion Semiconductor Sequencing




    • Single-molecule Real-time Sequencing (SMRT)







  • Nanopore Sequencing






  • UK NGS-based RNA-sequencing By Application







    • Expression Profiling Analysis







  • Small RNA Sequencing




  • De Novo Transcriptome Assembly






  • Variant Calling and Transcriptome Epigenetics






  • UK NGS-based RNA-sequencing By End-user






  • Research and Academia




  • Hospitals and Clinics






  • Pharmaceutical and Biotechnology Companies






  • ITALY Outlook (USD Billion, 2019-2032)




  • ITALY NGS-based RNA-sequencing By Product & Services




    • Sample Preparation Products




    • Sequencing Platforms and Consumables




    • Sequencing Services




    • Data Analysis, Storage and Management








  • ITALY NGS-based RNA-sequencing By Technology







    • Sequencing By Synthesis (SBS)




    • Ion Semiconductor Sequencing




    • Single-molecule Real-time Sequencing (SMRT)







  • Nanopore Sequencing






  • ITALY NGS-based RNA-sequencing By Application







    • Expression Profiling Analysis







  • Small RNA Sequencing




  • De Novo Transcriptome Assembly






  • Variant Calling and Transcriptome Epigenetics






  • ITALY NGS-based RNA-sequencing By End-user






  • Research and Academia




  • Hospitals and Clinics






  • Pharmaceutical and Biotechnology Companies






  • SPAIN Outlook (USD Billion, 2019-2032)




  • Spain NGS-based RNA-sequencing By Product & Services




    • Sample Preparation Products




    • Sequencing Platforms and Consumables




    • Sequencing Services




    • Data Analysis, Storage and Management








  • SpainNGS-based RNA-sequencing By Technology







    • Sequencing By Synthesis (SBS)




    • Ion Semiconductor Sequencing




    • Single-molecule Real-time Sequencing (SMRT)







  • Nanopore Sequencing






  • SpainNGS-based RNA-sequencing By Application







    • Expression Profiling Analysis







  • Small RNA Sequencing




  • De Novo Transcriptome Assembly






  • Variant Calling and Transcriptome Epigenetics






  • Spain NGS-based RNA-sequencing By End-user






  • Research and Academia




  • Hospitals and Clinics






  • Pharmaceutical and Biotechnology Companies






  • Rest Of Europe Outlook (USD Billion, 2019-2032)




  • Rest Of Europe NGS-based RNA-sequencing By Product & Services




    • Sample Preparation Products




    • Sequencing Platforms and Consumables




    • Sequencing Services




    • Data Analysis, Storage and Management








  • REST OF EUROPE NGS-based RNA-sequencing By Technology







    • Sequencing By Synthesis (SBS)




    • Ion Semiconductor Sequencing




    • Single-molecule Real-time Sequencing (SMRT)







  • Nanopore Sequencing






  • REST OF EUROPE NGS-based RNA-sequencing By Application







    • Expression Profiling Analysis







  • Small RNA Sequencing




  • De Novo Transcriptome Assembly






  • Variant Calling and Transcriptome Epigenetics






  • Rest Of Europe NGS-based RNA-sequencing By End-user






  • Research and Academia




  • Hospitals and Clinics






  • Pharmaceutical and Biotechnology Companies






  • Asia-Pacific Outlook (USD Billion, 2019-2032)




  • Asia-Pacific NGS-based RNA-sequencing By Product & Services




    • Sample Preparation Products




    • Sequencing Platforms and Consumables




    • Sequencing Services




    • Data Analysis, Storage and Management








  • Asia-Pacific NGS-based RNA-sequencing By Technology







    • Sequencing By Synthesis (SBS)




    • Ion Semiconductor Sequencing




    • Single-molecule Real-time Sequencing (SMRT)







  • Nanopore Sequencing






  • Asia-Pacific NGS-based RNA-sequencing By Application







    • Expression Profiling Analysis







  • Small RNA Sequencing




  • De Novo Transcriptome Assembly






  • Variant Calling and Transcriptome Epigenetics






  • Asia-Pacific NGS-based RNA-sequencing By End-user






  • Research and Academia




  • Hospitals and Clinics






  • Pharmaceutical and Biotechnology Companies






  • China Outlook (USD Billion, 2019-2032)




  • China NGS-based RNA-sequencing By Product & Services




    • Sample Preparation Products




    • Sequencing Platforms and Consumables




    • Sequencing Services




    • Data Analysis, Storage and Management








  • China NGS-based RNA-sequencing By Technology







    • Sequencing By Synthesis (SBS)




    • Ion Semiconductor Sequencing




    • Single-molecule Real-time Sequencing (SMRT)







  • Nanopore Sequencing






  • China NGS-based RNA-sequencing By Application







    • Expression Profiling Analysis







  • Small RNA Sequencing




  • De Novo Transcriptome Assembly






  • Variant Calling and Transcriptome Epigenetics






  • China NGS-based RNA-sequencing By End-user






  • Research and Academia




  • Hospitals and Clinics






  • Pharmaceutical and Biotechnology Companies






  • Japan Outlook (USD Billion, 2019-2032)




  • Japan NGS-based RNA-sequencing By Product & Services




    • Sample Preparation Products




    • Sequencing Platforms and Consumables




    • Sequencing Services




    • Data Analysis, Storage and Management








  • Japan NGS-based RNA-sequencing By Technology







    • Sequencing By Synthesis (SBS)




    • Ion Semiconductor Sequencing




    • Single-molecule Real-time Sequencing (SMRT)







  • Nanopore Sequencing






  • Japan NGS-based RNA-sequencing By Application







    • Expression Profiling Analysis







  • Small RNA Sequencing




  • De Novo Transcriptome Assembly






  • Variant Calling and Transcriptome Epigenetics






  • Japan NGS-based RNA-sequencing By End-user






  • Research and Academia




  • Hospitals and Clinics






  • Pharmaceutical and Biotechnology Companies






  • India Outlook (USD Billion, 2019-2032)




  • India NGS-based RNA-sequencing By Product & Services




    • Sample Preparation Products




    • Sequencing Platforms and Consumables




    • Sequencing Services




    • Data Analysis, Storage and Management








  • India NGS-based RNA-sequencing By Technology







    • Sequencing By Synthesis (SBS)




    • Ion Semiconductor Sequencing




    • Single-molecule Real-time Sequencing (SMRT)







  • Nanopore Sequencing






  • India NGS-based RNA-sequencing By Application







    • Expression Profiling Analysis







  • Small RNA Sequencing




  • De Novo Transcriptome Assembly






  • Variant Calling and Transcriptome Epigenetics






  • India NGS-based RNA-sequencing By End-user






  • Research and Academia




  • Hospitals and Clinics






  • Pharmaceutical and Biotechnology Companies






  • Australia Outlook (USD Billion, 2019-2032)




  • Australia NGS-based RNA-sequencing By Product & Services




    • Sample Preparation Products




    • Sequencing Platforms and Consumables




    • Sequencing Services




    • Data Analysis, Storage and Management








  • Australia NGS-based RNA-sequencing By Technology







    • Sequencing By Synthesis (SBS)




    • Ion Semiconductor Sequencing




    • Single-molecule Real-time Sequencing (SMRT)







  • Nanopore Sequencing






  • Australia NGS-based RNA-sequencing By Application







    • Expression Profiling Analysis







  • Small RNA Sequencing




  • De Novo Transcriptome Assembly






  • Variant Calling and Transcriptome Epigenetics






  • Australia NGS-based RNA-sequencing By End-user






  • Research and Academia




  • Hospitals and Clinics




  • Pharmaceutical and Biotechnology Companies






  • Rest of Asia-Pacific Outlook (USD Billion, 2019-2032)




  • Rest of Asia-Pacific NGS-based RNA-sequencing By Product & Services




    • Sample Preparation Products




    • Sequencing Platforms and Consumables




    • Sequencing Services




    • Data Analysis, Storage and Management








  • Rest of Asia-Pacific NGS-based RNA-sequencing By Technology







    • Sequencing By Synthesis (SBS)




    • Ion Semiconductor Sequencing




    • Single-molecule Real-time Sequencing (SMRT)







  • Nanopore Sequencing






  • Rest of Asia-Pacific NGS-based RNA-sequencing By Application







    • Expression Profiling Analysis







  • Small RNA Sequencing




  • De Novo Transcriptome Assembly






  • Variant Calling and Transcriptome Epigenetics






  • Rest of Asia-Pacific NGS-based RNA-sequencing By End-user






  • Research and Academia




  • Hospitals and Clinics




  • Pharmaceutical and Biotechnology Companies






  • Rest of the World Outlook (USD Billion, 2019-2032)




  • Rest of the World NGS-based RNA-sequencing By Product & Services




    • Sample Preparation Products




    • Sequencing Platforms and Consumables




    • Sequencing Services




    • Data Analysis, Storage and Management








  • Rest of the World NGS-based RNA-sequencing By Technology







    • Sequencing By Synthesis (SBS)




    • Ion Semiconductor Sequencing




    • Single-molecule Real-time Sequencing (SMRT)







  • Nanopore Sequencing






  • Rest of the World NGS-based RNA-sequencing By Application







    • Expression Profiling Analysis







  • Small RNA Sequencing




  • De Novo Transcriptome Assembly






  • Variant Calling and Transcriptome Epigenetics






  • Rest of the World NGS-based RNA-sequencing By End-user






  • Research and Academia




  • Hospitals and Clinics




  • Pharmaceutical and Biotechnology Companies




Middle East Outlook (USD Billion, 2019-2032)




  • Middle East NGS-based RNA-sequencing By Product & Services




    • Sample Preparation Products




    • Sequencing Platforms and Consumables




    • Sequencing Services




    • Data Analysis, Storage and Management








  • Middle East NGS-based RNA-sequencing By Technology







    • Sequencing By Synthesis (SBS)




    • Ion Semiconductor Sequencing




    • Single-molecule Real-time Sequencing (SMRT)







  • Nanopore Sequencing






  • Middle East NGS-based RNA-sequencing By Application







    • Expression Profiling Analysis







  • Small RNA Sequencing




  • De Novo Transcriptome Assembly






  • Variant Calling and Transcriptome Epigenetics






  • Middle East NGS-based RNA-sequencing By End-user






  • Research and Academia




  • Hospitals and Clinics




  • Pharmaceutical and Biotechnology Companies






  • Africa Outlook (USD Billion, 2019-2032)




  • Africa NGS-based RNA-sequencing By Product & Services




    • Sample Preparation Products




    • Sequencing Platforms and Consumables




    • Sequencing Services




    • Data Analysis, Storage and Management








  • Africa NGS-based RNA-sequencing By Technology







    • Sequencing By Synthesis (SBS)




    • Ion Semiconductor Sequencing




    • Single-molecule Real-time Sequencing (SMRT)







  • Nanopore Sequencing






  • Africa NGS-based RNA-sequencing By Application







    • Expression Profiling Analysis







  • Small RNA Sequencing




  • De Novo Transcriptome Assembly






  • Variant Calling and Transcriptome Epigenetics






  • Africa NGS-based RNA-sequencing By End-user






  • Research and Academia




  • Hospitals and Clinics




  • Pharmaceutical and Biotechnology Companies






  • Latin America Outlook (USD Billion, 2019-2032)




  • Latin America NGS-based RNA-sequencing By Product & Services




    • Sample Preparation Products




    • Sequencing Platforms and Consumables




    • Sequencing Services




    • Data Analysis, Storage and Management








  • Latin America NGS-based RNA-sequencing By Technology







    • Sequencing By Synthesis (SBS)




    • Ion Semiconductor Sequencing




    • Single-molecule Real-time Sequencing (SMRT)







  • Nanopore Sequencings






  • Latin America NGS-based RNA-sequencing By Application







    • Expression Profiling Analysis







  • Small RNA Sequencing




  • De Novo Transcriptome Assembly






  • Variant Calling and Transcriptome Epigenetics






  • Latin NGS-based RNA-sequencing By End-user






  • Research and Academia




  • Hospitals and Clinics




  • Pharmaceutical and Biotechnology Companies



Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Please fill in Business Email for Quick Response

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET INTRODUCTION

2.1. Definition

2.2. Scope of the Study

2.2.1. Research Objective

2.2.2. Assumptions

2.2.3.Limitations

3. RESEARCH METHODOLOGY

3.1. Overview

3.2. Data Mining

3.3. Secondary Research

3.4. Primary Research

3.4.1. Primary Interviews and Information Gathering Process

3.4.2.Breakdown of Primary Respondents

3.5. Forecasting Model

3.6. Market Size Estimation

3.6.1. Bottom-Up Approach

3.6.2. Top-Down Approach

3.7. Data Triangulation

3.8. Validation

4. MARKET DYNAMICS

4.1. Overview

4.2. Drivers

4.3. Restraints

4.4. Opportunities

5. MARKET FACTOR ANALYSIS

5.1. Value Chain Analysis

5.2. Porter’s Five Forces Analysis

5.2.1. Bargaining Power of Suppliers

5.2.2. Bargaining Power of Buyers

5.2.3. Threat of New Entrants

5.2.4. Threat of Substitutes

5.2.5. Intensity of Rivalry

5.3. COVID-19 Impact Analysis

5.3.1. Market Impact Analysis

5.3.2. Regional Impact

5.3.3. Opportunity and Threat Analysis

6. GLOBAL NGS-BASED RNA-SEQUENCING MARKET, BY PRODUCT AND SERVICE

6.1. Overview

6.2. Sample Preparation Products

6.3. Sequencing Platforms and Consumables

6.4. Sequencing Services

6.5. Data Analysis, Storage and Management

7. GLOBAL NGS-BASED RNA-SEQUENCING MARKET, BY TECHNOLOGY

7.1. Overview

7.2. Sequencing by Synthesis (SBS)

7.3. Ion Semiconductor Sequencing

7.4. Single-molecule Real-time Sequencing (SMRT)

7.5. Nanopore Sequencing

8. GLOBAL NGS-BASED RNA-SEQUENCING MARKET, BY APPLICATION

8.1. Overview

8.2. Expression Profiling Analysis

8.3. Small RNA Sequencing

8.4. De Novo Transcriptome Assembly

8.5. Variant Calling and Transcriptome Epigenetics

9. GLOBAL NGS-BASED RNA-SEQUENCING MARKET, BY END-USER

9.1. Overview

9.2. Research and Academia

9.3. Hospitals and Clinics

9.4. Pharmaceutical and Biotechnology Companies

10. GLOBAL NGS-BASED RNA-SEQUENCING MARKET, BY REGION

10.1. Overview

10.1. North America

10.1.1. US

10.1.2. Canada

10.2. Europe

10.2.1. Germany

10.2.2. France

10.2.3. UK

10.2.4. Italy

10.2.5. Spain

10.2.6. Rest of Europe

10.3. Asia-Pacific

10.3.1. China

10.3.2. India

10.3.3. Japan

10.3.4. South Korea

10.3.5. Australia

10.3.6. Rest of Asia-Pacific

10.4. Rest of the World

10.4.1. Middle East

10.4.2. Africa

10.4.3. Latin America

11. COMPETITIVE LANDSCAPE

11.1. Overview

11.2. Competitive Analysis

11.3. Market Share Analysis

11.4. Major Growth Strategy in the Global NGS-based RNA-sequencing Market,

11.5. Competitive Benchmarking

11.6. Leading Players in Terms of Number of Developments in the Global NGS-based RNA-sequencing Market,

11.7. Key developments and Growth Strategies

11.7.1. New Product and Service Launch/Service Deployment

11.7.2. Merger & Acquisitions

11.7.3. Joint Ventures

11.8. Major Players Financial Matrix

11.8.1. Sales & Operating Income, 2023

11.8.2. Major Players R&D Expenditure. 2023

12. COMPANY PROFILES

12.1. Illumina

12.1.1. Company Overview

12.1.2. Financial Overview

12.1.3. Product and Services Offered

12.1.4. Key Developments

12.1.5. SWOT Analysis

12.1.6. Key Strategies

12.2. Thermo Fischer Scientific

12.2.1. Company Overview

12.2.2. Financial Overview

12.2.3. Product and Services Offered

12.2.4. Key Developments

12.2.5. SWOT Analysis

12.2.6. Key Strategies

12.3. Oxford Nanopore

12.3.1. Company Overview

12.3.2. Financial Overview

12.3.3. Product and Services Offered

12.3.4. Key Developments

12.3.5. SWOT Analysis

12.3.6. Key Strategies

12.4. Agilent Technologies, Inc.

12.4.1. Company Overview

12.4.2. Financial Overview

12.4.3. Product and Services Offered

12.4.4. Key Developments

12.4.5. SWOT Analysis

12.4.6. Key Strategies

12.5. BGI

12.5.1. Company Overview

12.5.2. Financial Overview

12.5.3. Product and Services Offered

12.5.4. Key Developments

12.5.5. SWOT Analysis

12.5.6. Key Strategies

12.6. PerkinElmer Inc.

12.6.1. Company Overview

12.6.2. Financial Overview

12.6.3. Product and Services Offered

12.6.4. Key Developments

12.6.5. SWOT Analysis

12.6.6. Key Strategies

12.7. QIAGEN

12.7.1. Company Overview

12.7.2. Financial Overview

12.7.3. Product and Services Offered

12.7.4. Key Developments

12.7.5. SWOT Analysis

12.7.6. Key Strategies

12.8. EUROFINS SCIENTIFIC

12.8.1. Company Overview

12.8.2. Financial Overview

12.8.3. Product and Services Offered

12.8.4. Key Developments

12.8.5. SWOT Analysis

12.8.6. Key Strategies

12.9. Hoffmann-La Roche Ltd

12.9.1. Company Overview

12.9.2. Financial Overview

12.9.3. Product and Services Offered

12.9.4. Key Developments

12.9.5. SWOT Analysis

12.9.6. Key Strategies

12.10. Takara Bio Inc.

12.10.1. Company Overview

12.10.2. Financial Overview

12.10.3. Product and Services Offered

12.10.4. Key Developments

12.10.5. SWOT Analysis

12.10.6. Key Strategies

12.11. Tecan Genomics, Inc

12.11.1. Company Overview

12.11.2. Financial Overview

12.11.3. Product and Services Offered

12.11.4. Key Developments

12.11.5. SWOT Analysis

12.11.6. Key Strategies

13. APPENDIX

13.1. References

13.2. Related Reports

LIST OF TABLES

TABLE 1 GLOBAL NGS-BASED RNA-SEQUENCING MARKET, SYNOPSIS, 2019-2032

TABLE 2 GLOBAL NGS-BASED RNA-SEQUENCING MARKET, ESTIMATES & FORECAST, 2019-2032 (USD BILLION)

TABLE 3 GLOBAL NGS-BASED RNA-SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2019-2032 (USD BILLION)

TABLE 4 GLOBAL NGS-BASED RNA-SEQUENCING MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)

TABLE 5 GLOBAL NGS-BASED RNA-SEQUENCING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 6 GLOBAL NGS-BASED RNA-SEQUENCING MARKET, BY END-USER, 2019-2032 (USD BILLION)

TABLE 7 NORTH AMERICA: NGS-BASED RNA-SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2019-2032 (USD BILLION)

TABLE 8 NORTH AMERICA: NGS-BASED RNA-SEQUENCING MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)

TABLE 9 NORTH AMERICA: NGS-BASED RNA-SEQUENCING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 10 NORTH AMERICA: NGS-BASED RNA-SEQUENCING MARKET, BY END-USER, 2019-2032 (USD BILLION)

TABLE 11 US: NGS-BASED RNA-SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2019-2032 (USD BILLION)

TABLE 12 US: NGS-BASED RNA-SEQUENCING MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)

TABLE 13 US: NGS-BASED RNA-SEQUENCING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 14 US: NGS-BASED RNA-SEQUENCING MARKET, BY END-USER, 2019-2032 (USD BILLION)

TABLE 15 CANADA: NGS-BASED RNA-SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2019-2032 (USD BILLION)

TABLE 16 CANADA: NGS-BASED RNA-SEQUENCING MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)

TABLE 17 CANADA: NGS-BASED RNA-SEQUENCING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 18 CANADA: NGS-BASED RNA-SEQUENCING MARKET, BY END-USER, 2019-2032 (USD BILLION)

TABLE 1 EUROPE: NGS-BASED RNA-SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2019-2032 (USD BILLION)

TABLE 2 EUROPE: NGS-BASED RNA-SEQUENCING MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)

TABLE 3 EUROPE: NGS-BASED RNA-SEQUENCING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 4 EUROPE: NGS-BASED RNA-SEQUENCING MARKET, BY END-USER, 2019-2032 (USD BILLION)

TABLE 5 GERMANY: NGS-BASED RNA-SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2019-2032 (USD BILLION)

TABLE 6 GERMANY: NGS-BASED RNA-SEQUENCING MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)

TABLE 7 GERMANY: NGS-BASED RNA-SEQUENCING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 8 GERMANY: NGS-BASED RNA-SEQUENCING MARKET, BY END-USER, 2019-2032 (USD BILLION)

TABLE 9 FRANCE: NGS-BASED RNA-SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2019-2032 (USD BILLION)

TABLE 10 FRANCE: NGS-BASED RNA-SEQUENCING MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)

TABLE 11 FRANCE: NGS-BASED RNA-SEQUENCING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 12 FRANCE: NGS-BASED RNA-SEQUENCING MARKET, BY END-USER, 2019-2032 (USD BILLION)

TABLE 13 ITALY: NGS-BASED RNA-SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2019-2032 (USD BILLION)

TABLE 14 ITALY: NGS-BASED RNA-SEQUENCING MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)

TABLE 15 ITALY: NGS-BASED RNA-SEQUENCING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 16 ITALY: NGS-BASED RNA-SEQUENCING MARKET, BY END-USER, 2019-2032 (USD BILLION)

TABLE 17 SPAIN: NGS-BASED RNA-SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2019-2032 (USD BILLION)

TABLE 18 SPAIN: NGS-BASED RNA-SEQUENCING MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)

TABLE 19 SPAIN: NGS-BASED RNA-SEQUENCING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 20 SPAIN: NGS-BASED RNA-SEQUENCING MARKET, BY END-USER, 2019-2032 (USD BILLION)

TABLE 21 UK: NGS-BASED RNA-SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2019-2032 (USD BILLION)

TABLE 22 UK: NGS-BASED RNA-SEQUENCING MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)

TABLE 23 UK: NGS-BASED RNA-SEQUENCING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 24 UK: NGS-BASED RNA-SEQUENCING MARKET, BY END-USER, 2019-2032 (USD BILLION)

TABLE 25 REST OF EUROPE: NGS-BASED RNA-SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2019-2032 (USD BILLION)

TABLE 26 REST OF EUROPE: NGS-BASED RNA-SEQUENCING MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)

TABLE 27 REST OF EUROPE: NGS-BASED RNA-SEQUENCING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 28 REST OF EUROPE: NGS-BASED RNA-SEQUENCING MARKET, BY END-USER, 2019-2032 (USD BILLION)

TABLE 29 ASIA-PACIFIC: NGS-BASED RNA-SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2019-2032 (USD BILLION)

TABLE 30 ASIA-PACIFIC: NGS-BASED RNA-SEQUENCING MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)

TABLE 31 ASIA-PACIFIC: NGS-BASED RNA-SEQUENCING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 32 ASIA-PACIFIC: NGS-BASED RNA-SEQUENCING MARKET, BY END-USER, 2019-2032 (USD BILLION)

TABLE 33 JAPAN: NGS-BASED RNA-SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2019-2032 (USD BILLION)

TABLE 34 JAPAN: NGS-BASED RNA-SEQUENCING MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)

TABLE 35 JAPAN: NGS-BASED RNA-SEQUENCING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 36 JAPAN: NGS-BASED RNA-SEQUENCING MARKET, BY END-USER, 2019-2032 (USD BILLION)

TABLE 37 CHINA: NGS-BASED RNA-SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2019-2032 (USD BILLION)

TABLE 38 CHINA: NGS-BASED RNA-SEQUENCING MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)

TABLE 39 CHINA: NGS-BASED RNA-SEQUENCING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 40 CHINA: NGS-BASED RNA-SEQUENCING MARKET, BY END-USER, 2019-2032 (USD BILLION)

TABLE 41 INDIA: NGS-BASED RNA-SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2019-2032 (USD BILLION)

TABLE 42 INDIA: NGS-BASED RNA-SEQUENCING MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)

TABLE 43 INDIA: NGS-BASED RNA-SEQUENCING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 44 INDIA: NGS-BASED RNA-SEQUENCING MARKET, BY END-USER, 2019-2032 (USD BILLION)

TABLE 45 AUSTRALIA: NGS-BASED RNA-SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2019-2032 (USD BILLION)

TABLE 46 AUSTRALIA: NGS-BASED RNA-SEQUENCING MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)

TABLE 47 AUSTRALIA: NGS-BASED RNA-SEQUENCING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 48 AUSTRALIA: NGS-BASED RNA-SEQUENCING MARKET, BY END-USER, 2019-2032 (USD BILLION)

TABLE 49 SOUTH KOREA: NGS-BASED RNA-SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2019-2032 (USD BILLION)

TABLE 50 SOUTH KOREA: NGS-BASED RNA-SEQUENCING MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)

TABLE 51 SOUTH KOREA: NGS-BASED RNA-SEQUENCING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 52 SOUTH KOREA: NGS-BASED RNA-SEQUENCING MARKET, BY END-USER, 2019-2032 (USD BILLION)

TABLE 53 REST OF ASIA-PACIFIC: NGS-BASED RNA-SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2019-2032 (USD BILLION)

TABLE 54 REST OF ASIA-PACIFIC: NGS-BASED RNA-SEQUENCING MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)

TABLE 55 REST OF ASIA-PACIFIC: NGS-BASED RNA-SEQUENCING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 56 REST OF ASIA-PACIFIC: NGS-BASED RNA-SEQUENCING MARKET, BY END-USER, 2019-2032 (USD BILLION)

TABLE 57 REST OF THE WORLD: NGS-BASED RNA-SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2019-2032 (USD BILLION)

TABLE 58 REST OF THE WORLD: NGS-BASED RNA-SEQUENCING MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)

TABLE 59 REST OF THE WORLD: NGS-BASED RNA-SEQUENCING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 60 REST OF THE WORLD: NGS-BASED RNA-SEQUENCING MARKET, BY END-USER, 2019-2032 (USD BILLION)

TABLE 61 MIDDLE EAST: NGS-BASED RNA-SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2019-2032 (USD BILLION)

TABLE 62 MIDDLE EAST: NGS-BASED RNA-SEQUENCING MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)

TABLE 63 MIDDLE EAST: NGS-BASED RNA-SEQUENCING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 64 MIDDLE EAST: NGS-BASED RNA-SEQUENCING MARKET, BY END-USER, 2019-2032 (USD BILLION)

TABLE 65 AFRICA: NGS-BASED RNA-SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2019-2032 (USD BILLION)

TABLE 66 AFRICA: NGS-BASED RNA-SEQUENCING MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)

TABLE 67 AFRICA: NGS-BASED RNA-SEQUENCING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 68 AFRICA: NGS-BASED RNA-SEQUENCING MARKET, BY END-USER, 2019-2032 (USD BILLION)

TABLE 69 LATIN AMERICA: NGS-BASED RNA-SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2019-2032 (USD BILLION)

TABLE 70 LATIN AMERICA: NGS-BASED RNA-SEQUENCING MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)

TABLE 71 LATIN AMERICA: NGS-BASED RNA-SEQUENCING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)

TABLE 72 LATIN AMERICA: NGS-BASED RNA-SEQUENCING MARKET, BY END-USER, 2019-2032 (USD BILLION)

LIST OF FIGURES

FIGURE 1 RESEARCH PROCESS

FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL NGS-BASED RNA-SEQUENCING MARKET

FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL NGS-BASED RNA-SEQUENCING MARKET

FIGURE 4 GLOBAL NGS-BASED RNA-SEQUENCING MARKET, SHARE (%), BY PRODUCT AND SERVICE, 2023

FIGURE 5 GLOBAL NGS-BASED RNA-SEQUENCING MARKET, SHARE (%), BY TECHNOLOGY, 2023

FIGURE 6 GLOBAL NGS-BASED RNA-SEQUENCING MARKET, SHARE (%), BY APPLICATION, 2023

FIGURE 7 GLOBAL NGS-BASED RNA-SEQUENCING MARKET, SHARE (%), BY END-USER, 2023

FIGURE 8 GLOBAL NGS-BASED RNA-SEQUENCING MARKET, SHARE (%), BY REGION, 2023

FIGURE 9 NORTH AMERICA: NGS-BASED RNA-SEQUENCING MARKET, SHARE (%), BY REGION, 2023

FIGURE 10 EUROPE: NGS-BASED RNA-SEQUENCING MARKET, SHARE (%), BY REGION, 2023

FIGURE 11 ASIA-PACIFIC: NGS-BASED RNA-SEQUENCING MARKET, SHARE (%), BY REGION, 2023

FIGURE 12 REST OF THE WORLD: NGS-BASED RNA-SEQUENCING MARKET, SHARE (%), BY REGION, 2023

FIGURE 13 GLOBAL NGS-BASED RNA-SEQUENCING MARKET: COMPANY SHARE ANALYSIS, 2023 (%)

FIGURE 14 ILLUMINA: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 15 ILLUMINA: SWOT ANALYSIS

FIGURE 16 THERMO FISCHER SCIENTIFIC: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 17 THERMO FISCHER SCIENTIFIC: SWOT ANALYSIS

FIGURE 18 OXFORD NANOPORE: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 19 OXFORD NANOPORE: SWOT ANALYSIS

FIGURE 20 AGILENT TECHNOLOGIES, INC.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 21 AGILENT TECHNOLOGIES, INC.: SWOT ANALYSIS

FIGURE 22 BGI.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 23 BGI.: SWOT ANALYSIS

FIGURE 24 PERKINELMER INC.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 25 PERKINELMER INC.: SWOT ANALYSIS

FIGURE 26 QIAGEN: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 27 QIAGEN: SWOT ANALYSIS

FIGURE 28 EUROFINS SCIENTIFIC: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 29 EUROFINS SCIENTIFIC: SWOT ANALYSIS

FIGURE 30 HOFFMANN-LA ROCHE LTD: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 31 HOFFMANN-LA ROCHE LTD: SWOT ANALYSIS

FIGURE 32 TAKARA BIO INC.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 33 TAKARA BIO INC: SWOT ANALYSIS

FIGURE 34 TECAN GENOMICS, INC: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 35 TECAN GENOMICS, INC: SWOT ANALYSIS

Purchase Option
Single User $ 4,590
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.
Related Reports
report-img
Next Generation Sequencing Market Research Report - Forecast till 2032
report-img
SNP Genotyping and Analysis Market Research Report — Global Forecast till 2032
Press Release
Category icon
NGS-based RNA-sequencing Market is predicted to reach USD 12.4 billion at a CAGR of 21.00% during...
Logo
Dmca Cloudflare ssl
Paypal footer Ssl
Services Industry Expertise Consulting Services Articles How To Order FAQs
Our Company About US Careers Contact Us Terms & Conditions Privacy Policy
Banking Partners
Amex Mastercard1
Razerpay
Hdfcbank
Visa
✉  info@marketresearchfuture.com
📞  +1 (855) 661-4441(US)
📞  +44 1720 412 167(UK)

© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)